BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32540330)

  • 21. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervix.
    Jacob D; Lamberto M; DeSouza Lawrence L; Mourtada F
    Brachytherapy; 2017; 16(3):624-629. PubMed ID: 28365083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies.
    Bajwa HK; Singareddy R; Krishnam Raju A
    Brachytherapy; 2020; 19(5):669-673. PubMed ID: 32466952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Volumetric image guidance for intravaginal brachytherapy: A dosimetric and clinical study.
    Udayashankara AH; Srikantia N; Muzumder S; Chandramouli SH; Raj JM; Shariff MH
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S320-S327. PubMed ID: 36510983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning.
    Bahadur YA; Constantinescu C; Hassouna AH; Eltaher MM; Ghassal NM; Awad NA
    J Contemp Brachytherapy; 2015 Jan; 6(4):362-70. PubMed ID: 25834580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
    Gebhardt BJ; Vargo JA; Kim H; Houser CJ; Glaser SM; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Courtney-Brooks M; Beriwal S
    Gynecol Oncol; 2018 Aug; 150(2):293-299. PubMed ID: 29929925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SU-E-T-306: An Optimized Dosimetry Study Comparing a Multichannel Cylinder versus Single Channel Cylinder in the Treatment of the Vaginal Cuff or Vagina with High Dose Rate Brachytherapy.
    Rosen L; Syh J; Patel B; Syh J; Wu H
    Med Phys; 2012 Jun; 39(6Part14):3774. PubMed ID: 28517268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
    Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
    Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do changes in interfraction organ at risk volume and cylinder insertion geometry impact delivered dose in high-dose-rate vaginal cuff brachytherapy?
    Patel S; Mehta KJ; Kuo HC; Ohri N; Patel R; Yaparpalvi R; Garg MK; Guha C; Kalnicki S
    Brachytherapy; 2016; 15(2):185-90. PubMed ID: 26796601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating dose distributions of high dose rate
    Aloraibi HA; Siavashpour Z; Ghorbani M; Abtahi M; Jassim H; Gholami S
    Appl Radiat Isot; 2024 Feb; 204():111124. PubMed ID: 38029638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer.
    Pedicini P; Strigari L; Caivano R; Fiorentino A; Califano G; Nappi A; Improta G; Storto G; Cozzolino M; Chiumento C; Fusco V; Vavassori A; Benassi M; Orecchia R; Salvatore M
    J Appl Clin Med Phys; 2013 Mar; 14(2):4075. PubMed ID: 23470938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applicator-guided proton therapy versus multichannel brachytherapy for vaginal vault irradiation.
    Biltekin F; Bäumer C; Khalil DA; Gultekin M; Yildiz F; Timmermann B
    Phys Eng Sci Med; 2023 Sep; 46(3):1287-1295. PubMed ID: 37405636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
    Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
    Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant brachytherapy for endometrial cancer: advantages of the vaginal mold technique.
    El Khoury C; Dumas I; Tailleur A; Morice P; Haie-Meder C
    Brachytherapy; 2015; 14(1):51-5. PubMed ID: 25183208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal packing volume impact on dose parameters during radiography and computed tomography based postoperative brachytherapy of cervical carcinoma.
    Tomasevic A; Plesinac-Karapandzic V; Stojanovic-Rundic S; Vuckovic S; Stevanovic J; Gavrilovic D; Nadrljanski M
    J BUON; 2017; 22(6):1509-1516. PubMed ID: 29332346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index, dose to organs at risk during vaginal brachytherapy, and the role of three-dimensional CT-based treatment planning.
    Boyle JM; Craciunescu O; Steffey B; Cai J; Chino J
    Brachytherapy; 2014; 13(4):332-6. PubMed ID: 24439964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer.
    Kharouta MZ; Pham N; Nieto K; Surucu M; Mysz ML; Albuquerque K; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
    Brachytherapy; 2018; 17(4):673-679. PubMed ID: 29759329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.